Skip to Content

Tag: Part B infusion drugs


Specialty Providers

Deadline to sign infusion letter looms

January 19, 2017HME News Staff

WASHINGTON - The National Home Infusion Association seeks signatures for a letter that urges Congress to align the effective dates of switching to an average sales price reimbursement model for Part B infusion drugs.In the letter, addressed to Senate Majority Leader Mitch McConnell, Senate Minority Leader Charles Schumer, House Speaker Paul Ryan and Democratic Leader Nancy Pelosi, the association requests “quick action” to ensure beneficiaries have access to services, equipment and drugs.“The...

Average Sales Price, National Home Infusion Association, Part B infusion drugs


Read Full Articlered right arrow icon

Specialty Providers

Cures Act imposes ASP model for infusion drugs

December 9, 2016Theresa Flaherty, Managing Editor

WASHINGTON - While the broader HME industry is cheering the passage of the 21st Century Cures Act, home infusion is facing reimbursement cuts—effective almost immediately.The bill, on its way to the president for his signature, contains a provision that would shift payments for Part B home infusion drugs from an average wholesale price model to an average sales price model on Jan. 1.“The inclusion of the ASP model is not new, but what may be more startling is it's supposed to be implemented...

ASP Model, Home Infusion, National Home Infusion Association, Part B infusion drugs


Read Full Articlered right arrow icon